Skip to content
The Nexus
DossierENTITY

DemeRx

Coverage of DemeRx in the Nexus archive.

Earliest in view: Apr 24 · 14:53 UTCMost recent: Apr 24 · 14:53 UTC
Co-mentioned in this coverage
Food and Drug Administration (FDA)organization1Donald Trumpperson1psilocybintopic1methylonetopic1Robert F. Kennedy Jr.person1Make America Healthy Again movementtopic1ibogainetopic1
Recent coverage
  • HEALTHApr 24 · 14:53 UTCAP NEWS
    FDA plans ultra-fast review of three psychedelic drugs following Trump directive

    The FDA announced ultra-fast review timelines for three psychedelic drugs, including psilocybin and methylone, following an executive order by the Trump administration to accelerate access to psychedelics for mental health treatments. The move aligns with growing support from Trump allies and Health Secretary Robert F. Kennedy Jr.'s advocacy for psychedelic therapies.